Dr. Goetz is a consultant in the Division of Medical Oncology at Mayo Clinic in Rochester, Minn., and a professor of oncology and ****ociate professor of pharmacology at Mayo Clinic College of Medicine.

Dr. Boughey is a consultant in the Division of Subspecialty General Surgery at Mayo Clinic in Rochester, Minn., and a professor of surgery at Mayo Clinic College of Medicine. She is also program director of the Mayo Clinic Multidisciplinary Breast Surgery Fellowship and chair of the Committee on Education of the American College of Surgeons Clinical Research Program.

Cynthia X. Ma, MD, PhD, Washington University School of Medicine, St. Louis, MI, updates us on recent understanding of potential resistance mechanisms to CDK4/6 inhibitors and therapeutic strategies for hormone receptor-positive (HR+) and HER2-negative (HER2-) metastatic breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Join Bridget and Thomas on their journey to learn how about their mother's breast cancer - how metastatic breast cancer affects the body, common symptoms, how metastatic breast cancer is treated, and the importance of a support system.

This video is kindly sponsored by Roche Australia and is proudly endorsed by McGrath Foundation and Breast Cancer Network Australia.

More than 160,000 women in the US are living with Metastatic Breast Cancer. Also known as Stage IV breast cancer, Metastatic Breast Cancer is breast cancer that has spread to other parts of the body. Metastatic Breast Cancer can be treated, but not cured.

Lynda Weatherby went from a Stage 0 DCIS & bilateral mastectomy in 2001 to a recurrence & Stage IV MBC diagnosis 12 years later, with metastases all through her bones, to her brain, and a facial nerve. Hear how Lynda has managed her brain mets treatments and advocates for more breast cancer brain mets research today.

This video is part of the Metastatic Breast Cancer Alliance's Here All Year campaign. Breast Cancer Awareness Month is just October, but we're Here All Year.

When breast cancers spreads from the breast to other parts of the body, it is termed “metastatic”. The most common sites of spread in breast cancer are the bones, liver, lungs, and brain. At a metastatic diagnosis, doctors commonly scan the body for signs of spread, but most patients do not receive a brain scan unless they have symptoms like a numbness, or headaches. This month, the Metastatic Breast Cancer (MBC) Alliance is focusing on breast cancer brain metastasis. The incidence of brain metastasis is growing as new therapies help patients live longer with MBC. As in all things MBC, we need more research, earlier screening, and scientific breakthroughs. For a patient living with breast cancer brain mets, the need for research is enormous and HERE ALL YEAR.

Each month, our Here All Year campaign explores a new topic around metastatic breast cancer—from myth and stigma busters, to new research and strategies for improving outcomes. Want to help make a difference for people living with MBC, all year long? Dig deeper into the research, explore the available resources and share them on your social and email channels.

Bardia, Aditya,M.D. presents What's New and on the Horizon for Metastatic Breast Cancer? as part of the Johns Hopkins Breast Cancer Program's 2021 Lunch and Learn Series.

Joyce A. O’Shaughnessy, MD, and Andrew D. Seidman, MD, evaluate treatment options outside of CDK4/6 inhibition, such as PI3-kinase or poly(adenosine diphosphate–ribose) polymerase (PARP) inhibitors, for patients with hormone-receptor positive metastatic breast cancer.